News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Fibrocell Science, Inc. Enters into Agreement to Sell Majority Ownership Stake in Agera Laboratories for $0.85 Million


6/8/2012 9:38:23 AM

EXTON, Pa.--(BUSINESS WIRE)--Fibrocell Science, Inc. (OTCBB:FCSC) announced today that it has entered into a definitive agreement to sell its majority ownership stake in Agera Laboratories, a skincare company offering anti-aging, pigmentation and acne treatment products, to Rohto Pharmaceutical Co., Ltd. for $0.85 million. Within ten days, $0.40 million is to be paid and the remaining balance will be paid at the closing of the transaction, which is expected by August 31, 2012. Fibrocell acquired a 57 percent ownership stake in Agera Laboratories in August 2006.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES